CHAMPSI FARAH

CIK 000119832124 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001198321

Recent Transactions

50 trades

Other
Population Health Investment Co., Inc.
Class B Ordinary Shares
2021-01-26$250.00/sh+43,125→ 43,125 total
Other
Allakos Inc.
Common Stock
2020-01-22−1,000,000→ 10,519,200 total
Other
Allakos Inc.
Common Stock
2020-01-22+34,615→ 34,615 total
Other
Allakos Inc.
Common Stock
2020-01-22−34,615→ 0 total
Other
Allakos Inc.
Common Stock
2020-01-22+11,538→ 11,538 total
Other
Allakos Inc.
Common Stock
2020-01-22+11,538→ 11,538 total
Other
Allakos Inc.
Common Stock
2020-01-22+11,539→ 11,539 total
Other
Allakos Inc.
Common Stock
2020-01-22+6,837→ 6,837 total
Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2018-10-01+458,331→ 1,047,992 total
Conversion
SUTRO BIOPHARMA, INC.$STRO
Series E Preferred Stock
2018-10-01−18,698,578→ 0 total
Conversion
SUTRO BIOPHARMA, INC.$STRO
Series D Preferred Stock
2018-10-01−9,449,318→ 0 total
Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2018-10-01+589,661→ 589,661 total
Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2018-10-01+514,211→ 1,944,901 total
Conversion
SUTRO BIOPHARMA, INC.$STRO
Series B Preferred Stock
2018-10-01−10,201,769→ 0 total
Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2018-10-01+382,698→ 1,430,690 total
Conversion
SUTRO BIOPHARMA, INC.$STRO
Series C Preferred Stock
2018-10-01−12,387,324→ 0 total
Conversion
Allakos Inc.
Common Stock
2018-07-23+11,269,200→ 11,269,200 total
Conversion
Allakos Inc.
Series A Preferred Stock
2018-07-23−10,030,193→ 0 total
Purchase
Allakos Inc.
Common Stock
2018-07-23$18.00/sh+250,000→ 11,519,200 total
Conversion
Allakos Inc.
Series B Preferred Stock
2018-07-23−1,239,007→ 0 total
Disposition from Tender
Kite Pharma, Inc.
Common Stock
2017-10-03$180.00/sh−61,467→ 1,807 total
Disposition to Issuer
Kite Pharma, Inc.
Common Stock
2017-10-03−1,807→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Director Stock Option (Right to Buy)
2017-10-03$178.65/sh−50,000→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Director Stock Option (Right to Buy)
2017-10-03$120.77/sh−10,000→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Director Stock Option (Right to Buy)
2017-10-03$88.79/sh−8,810→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Director Stock Option (Right to Buy)
2017-10-03$129.13/sh−7,000→ 0 total
Gift
Kite Pharma, Inc.
Common Stock
2017-09-29−2,800→ 63,274 total
Award
Kite Pharma, Inc.
Common Stock
2017-06-20+2,410→ 66,074 total
Award
Kite Pharma, Inc.
Director Stock Option (Right to Buy)
2017-06-20+8,810→ 8,810 total
Sale
Kite Pharma, Inc.
Common Stock
2017-06-16$88.11/sh−5,450→ 0 total
Sale
Kite Pharma, Inc.
Common Stock
2017-06-14$90.40/sh−15,000→ 63,664 total
Sale
Kite Pharma, Inc.
Common Stock
2017-04-28$82.59/sh−2,617→ 4,962 total
Sale
Kite Pharma, Inc.
Common Stock
2017-04-27$82.77/sh−16,551→ 7,579 total
Sale
Kite Pharma, Inc.
Common Stock
2017-04-26$82.72/sh−51,112→ 24,330 total
Sale
Kite Pharma, Inc.
Common Stock
2017-04-26$83.06/sh−200→ 24,130 total
Sale
Kite Pharma, Inc.
Common Stock
2017-04-25$82.56/sh−31,467→ 90,758 total
Sale
Kite Pharma, Inc.
Common Stock
2017-04-25$83.29/sh−15,316→ 75,442 total
Sale
Kite Pharma, Inc.
Common Stock
2017-04-24$82.34/sh−25,818→ 122,225 total
Sale
Kite Pharma, Inc.
Common Stock
2017-04-17$82.48/sh−43,001→ 148,143 total
Sale
Kite Pharma, Inc.
Common Stock
2017-04-17$83.06/sh−100→ 148,043 total
Sale
Kite Pharma, Inc.
Common Stock
2017-04-13$82.39/sh−72,275→ 191,144 total
Award
Kite Pharma, Inc.
Common Stock
2016-06-01+1,950→ 21,616 total
Award
Kite Pharma, Inc.
Director Stock Option (Right to Buy)
2016-06-01+7,000→ 7,000 total
Sale
Evofem Biosciences, Inc.$EVFM
Common Stock
2015-12-30$1.44/sh−250,000→ 1,339,776 total
Sale
Evofem Biosciences, Inc.$EVFM
Common Stock
2015-12-29$1.53/sh−493,654→ 1,589,776 total
Sale
Evofem Biosciences, Inc.$EVFM
Common Stock
2015-12-28$1.59/sh−54,333→ 2,083,430 total
Sale
Evofem Biosciences, Inc.$EVFM
Common Stock
2015-12-15$1.44/sh−529,261→ 2,137,763 total
Sale
Kite Pharma, Inc.
Common Stock
2015-06-30$63.82/sh−500→ 1,761,957 total
Sale
Kite Pharma, Inc.
Common Stock
2015-06-30$62.14/sh−113,047→ 2,121,214 total
Sale
Kite Pharma, Inc.
Common Stock
2015-06-30$61.22/sh−191,798→ 2,234,261 total

Recent Filings

Address

ONE EMBARCADERO CENTER SUITE 3700

SAN FRANCISCO, CA, 94132

View on SEC.gov